Heriberto García, director of the agency, explained that five experts voted in favor of the vaccine being applied from this age, while two did so so that it started from the age of 12, and an expert requested more background.
This day the Institute of Public Health (ISP) met to analyze the use of the Sinovac Covid vaccine in children and adolescents between 3 and 17 years old. After the appointment, it was decided to authorize the use of the drug from the age of 6. The decision comes after the National Supply Center (Cenabast) requested authorization for the use of Coronovac in that age range. The petition was accompanied by information on the phase I and II clinical study conducted in China, as well as additional information. According to Heriberto García, director of the agency, five experts voted in favor of the vaccine being applied from the age of 6, while two did so so that it started from the age of 12, and an expert requested more background. “The ISP will issue a resolution allowing the vaccine from the age of 6. It will be linked to relevant drug-relvancia campaigns. We need the support, from you father and mother, to be attentive to any circumstance that affects the child and report the progress,” he added.